Skip to main content
Fig. 7 | Clinical Epigenetics

Fig. 7

From: Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma

Fig. 7

The combination of venetoclax and chidamide alters cell cycle distribution. A, B SC-1, C SU-DHL4, and D RL cells were treated with ABT199, CS055, or their combination for 48 h, and cell cycle distribution was detected by PI staining. Data were represented as mean ± SD in G0/G1 phase. **p < 0.01, ****p < 0.0001 and ns (not significant) by one‐way ANOVA

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us